Common Cold

• FDA approval · 2009-05-19
  FDA Approved: ADVIL COLD AND SINUS — Supplemental Application (Haleon US Holdings LLC)

  The FDA approved a supplemental application for Advil Cold and Sinus, incorporating ibuprofen with pseudoephedrine hydrochloride to expand l…

• FDA approval · 2009-04-03
  FDA Approved: MUCINEX DM MAXIMUM STRENGTH — Supplemental Application (RB Health (US) LLC)

  FDA approved a supplemental application for Mucinex DM Maximum Strength (guaifenesin and dextromethorphan hydrobromide) submitted by RB Heal…

• CLINICAL_TRIALS trial_result · 2009-02-13
  Clinical Trial Update: Kinetics of Etheric Oils, Smart Textiles vs. Ointment [Phase 1]

  Phase 1 trial updating on the kinetics of etheric oils delivered by smart textiles versus ointment for the common cold; the study status is …

• FDA approval · 2008-09-23
  FDA Approved: SINUS AND COLD D — Supplemental Application (Meijer Distribution Inc)

  FDA approved a supplemental application for Sinus and Cold D, a naproxen sodium and pseudoephedrine hydrochloride combination, distributed b…

• FDA approval · 2008-08-22
  FDA Approved: GOOD SENSE CHILDRENS IBUPROFEN — Supplemental Application (L. Perrigo Company)

  FDA approved a supplemental application for Good Sense Children’s Ibuprofen (ibuprofen) from L. Perrigo Company.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-08-18
  Clinical Trial Update: Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection [Phase 2]

  Phase 2 trial evaluating POMx pomegranate concentrate for preventing experimental rhinovirus infection in the context of the common cold has…

• CLINICAL_TRIALS trial_result · 2008-02-18
  Clinical Trial Update: Pomegranate Products for Prevention of Common Cold [Phase 3]

  Phase 3 trial evaluating pomegranate products for prevention of the common cold has completed.

• FDA approval · 2007-11-09
  FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)

  The FDA approved a supplemental application for ZYRTEC-D (cetirizine hydrochloride and pseudoephedrine hydrochloride) by Kenvue Brands LLC.

• FDA approval · 2007-09-06
  FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE — Supplemental Application (WALGREEN COMPANY)

  FDA approved Walgreens' supplemental application for Guaifenesin and Pseudoephedrine Hydrochloride.

• CLINICAL_TRIALS trial_result · 2007-05-03
  Clinical Trial Update: Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold [Phase 3]

  Phase 3 trial results update on the decongestant effectiveness, onset of action, and impact on sleep and general well-being of xylometazolin…

• FDA approval · 2006-12-19
  FDA Approved: SINUS AND COLD D — Supplemental Application (Meijer Distribution Inc)

  FDA approves a supplemental ANDA for Sinus and Cold D, a combination product containing naproxen sodium and pseudoephedrine hydrochloride di…

• CLINICAL_TRIALS trial_result · 2006-12-14
  Clinical Trial Update: Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers [Phase 3]

  A Phase 3 trial evaluating Echinacea, Propolis, and Vitamin C for preventing upper respiratory infections in preschoolers has completed.

• FDA approval · 2006-12-07
  FDA Approved: PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE — Original Application (Genus Lifesciences Inc.)

  FDA approved Genus Lifesciences' original application for a generic promethazine hydrochloride and phenylephrine hydrochloride product, a co…

• FDA approval · 2006-09-27
  FDA Approved: IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE — Supplemental Application (Rite-Aid)

  FDA approved a supplemental application for Rite Aid's ibuprofen and pseudoephedrine hydrochloride product, indicating an approval modificat…

• FDA approval · 2006-08-23
  FDA Approved: MUCINEX — Supplemental Application (RB Health (US) LLC)

  FDA approved a supplemental application for Mucinex (guaifenesin) from RB Health (US) LLC, indicating FDA action on a supplemental submissio…

• CLINICAL_TRIALS trial_result · 2006-08-18
  Clinical Trial Update: Evaluation of Echinacea for the Common Cold [Phase 2]

  Phase 2 clinical trial evaluating Echinacea for the common cold has completed.

• CLINICAL_TRIALS trial_result · 2006-08-18
  Clinical Trial Update: A Trial of Echinacea in Children [Phase 3]

  This document reports that a Phase 3 clinical trial testing echinacea in children for the common cold has completed.

• FDA approval · 2006-06-07
  FDA Approved: CARBZAH — Supplemental Application (IPG Pharmaceuticals, inc.)

  The FDA approved a supplemental application for CARBZAH (carbinoxamine maleate) from IPG Pharmaceuticals, Inc., indicating regulatory approv…